| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/13/2007 | US20070213297 Arrays with cleavable linkers |
| 09/13/2007 | US20070213296 Compositions and methods for the treatment of immunoinflammatory disorders |
| 09/13/2007 | US20070213295 Methods and compositions for inducing torpor in a subject |
| 09/13/2007 | US20070213294 Methods for modulating the axonal growth of central nervous system neurons |
| 09/13/2007 | US20070213291 Therapeutically useful synthetic oligonucleotides |
| 09/13/2007 | US20070213290 Neurite regeneration |
| 09/13/2007 | US20070213288 Adenoviral Vector Capable of Infecting Tumor Cells and Eliminating the Function of STAT3 |
| 09/13/2007 | US20070213287 Introducing nucleic acid encoding therapeutic gene product formulated with an anionic polymer selected from polyglutamic acid, polyaspartic acid, polygalacturonic acid, poly vinyl sulfate into cell |
| 09/13/2007 | US20070213285 Methods and compositions for cancer therapy |
| 09/13/2007 | US20070213284 Method of selecting targets for gene silencing by RNA interference |
| 09/13/2007 | US20070213283 Macrolides substituted at the 4"-position |
| 09/13/2007 | US20070213282 Peroxisome proliferator-activated receptor (PPAR) activator, and drugs, supplements, functional foods and food additives using the same |
| 09/13/2007 | US20070213281 Analogues of Oroxylin-A, Chrysin and Baicalein as antiulcer agents and mucoprotective agents from a new source new source Oroxylum indicum dried stem bark; flavanoids; gastrointestinal disorders; peptic ulcers; side effect reduction |
| 09/13/2007 | US20070213280 Steroidal Saponins Compound, the Process for Producing the Same and the Use Thereof |
| 09/13/2007 | US20070213279 O6-alkylguanine-dna alkyltransferase inactivators and beta-glucuronidase cleavable prodrugs |
| 09/13/2007 | US20070213278 Arrays with cleavable linkers |
| 09/13/2007 | US20070213277 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 09/13/2007 | US20070213275 Formulations for ecallantide |
| 09/13/2007 | US20070213271 Composition and method for treating hiv infection |
| 09/13/2007 | US20070213270 Peptide yy formulations having increased stability and resistance to microbial agents |
| 09/13/2007 | US20070213268 inhibiting angiogenesis in tissues expressing a endocrine gland-derived vascular endothelial growth factor(EG-VEGF) polypeptide, comprising contacting the tissue with an antagonist antibody of the EG-VEGF polypeptide or an antigen binding fragment; regulating cellular proliferation and chemotaxis |
| 09/13/2007 | US20070213261 Asthma Preparation |
| 09/13/2007 | US20070213259 Method for stabilizing blood pressure in hemodialysis subjects |
| 09/13/2007 | US20070213256 Novel genes and proteins encoded thereby |
| 09/13/2007 | US20070212769 Transfection, culturing; electrophoresis |
| 09/13/2007 | US20070212758 Methods for the production of 3-o-deactivated-4'-monophosphoryl lipid a (3d-mla) |
| 09/13/2007 | US20070212756 Methods for treating lentivirus infections |
| 09/13/2007 | US20070212714 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof |
| 09/13/2007 | US20070212431 Cream for treatment of skin injured by the sun |
| 09/13/2007 | US20070212430 Method for weight reduction |
| 09/13/2007 | US20070212429 Compositions and methods for increasing adipose metabolism, lipolysis or lipolytic metabolism via thermogenesis |
| 09/13/2007 | US20070212428 Methods and compositions for treating mood disorder |
| 09/13/2007 | US20070212427 Hormone replacement formulation |
| 09/13/2007 | US20070212426 Composition and method of retarding viral activity and reducing viral replication |
| 09/13/2007 | US20070212421 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 09/13/2007 | US20070212419 Synthesis of biocompatible nanocomposite hydrogels as a local drug delivery system |
| 09/13/2007 | US20070212417 Compressible resilient granules and formulations prepared therefrom |
| 09/13/2007 | US20070212416 Controlled Release Matrix Pharmaceutical Dosage Formulation |
| 09/13/2007 | US20070212415 Sustained-release tablet containing doxazosin mesylate |
| 09/13/2007 | US20070212414 Ethanol-resistant sustained release formulations |
| 09/13/2007 | US20070212413 Sustained-release oral molsidomine composition for treating atherosclerosis |
| 09/13/2007 | US20070212412 Stable solid formulation of sertindole |
| 09/13/2007 | US20070212409 Stable pharmaceutical compositions for 2-aza-bicyclo [3.30]-octane-3-carboxylic acid derivatives |
| 09/13/2007 | US20070212408 Stable Pharmaceutical Composition Containing Benzimidazole Derivatives and Method of Manufacturing the Same |
| 09/13/2007 | US20070212406 Homeopathic drug composition and methods of use thereof |
| 09/13/2007 | US20070212402 Patch |
| 09/13/2007 | US20070212395 Ocular therapy using sirtuin-activating agents |
| 09/13/2007 | US20070212394 Taxane coatings for implantable medical devices |
| 09/13/2007 | US20070212393 Compositions and coatings for implantable medical devices |
| 09/13/2007 | US20070212392 Chemoprevention of endometrial cancer |
| 09/13/2007 | US20070212391 Stabilised prostaglandin composition |
| 09/13/2007 | US20070212385 Fluidic Tissue Augmentation Compositions and Methods |
| 09/13/2007 | US20070212380 Conjugated Fatty Acid Based Emulsion and Methods for Preparing and Using Same |
| 09/13/2007 | US20070212371 Processes for preparing water-soluble polyethylene glycol conjugates of macrolide immunosuppressants |
| 09/13/2007 | US20070212370 Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells |
| 09/13/2007 | US20070212368 Proteins |
| 09/13/2007 | US20070212366 Use Of Mrp4-Inhibitors For The Treatment And/Or Prophylaxis Of Cardiovascular Diseases |
| 09/13/2007 | US20070212363 Immunoglobulins with Potent and Broad Antiviral Activity |
| 09/13/2007 | US20070212360 Modulation of mitochondrial oxygen consumption for therapeutic purposes |
| 09/13/2007 | US20070212358 Compositions and Methods for Effecting Controlled Posterior Vitreous Detachment |
| 09/13/2007 | US20070212352 Methods and compositions for the treatment of polycystic diseases |
| 09/13/2007 | US20070212351 Novel therapeutic targets in cancer |
| 09/13/2007 | US20070212348 Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation |
| 09/13/2007 | US20070212347 Compositions and methods for treating polycystic kidney disease gene |
| 09/13/2007 | US20070212346 Highly Concentrated Stabilized Igm Solution |
| 09/13/2007 | US20070212345 Methods And Compositions For The Prevention And Treatment Of Gentiourinary Disorders Including Pre-Term Labor And Leiomyomas |
| 09/13/2007 | US20070212344 Pharmaceutical preparation with RNA as hemostasis cofactor |
| 09/13/2007 | US20070212343 Compositions for treatment of ear infections |
| 09/13/2007 | US20070212339 Use Of At Least One Effector Of Glutathione Metabolism Together With Alpha-Lipoic Acid For The Treatment Of Chronically Obstructive Lung Diseases |
| 09/13/2007 | US20070212334 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 09/13/2007 | US20070212329 Vaccine Compositions Comprising An Interleukin 18 And Saponin Adjuvant System |
| 09/13/2007 | US20070212327 Allergen Depressant And Depression Method |
| 09/13/2007 | US20070212326 Polyquaternary organosilicon compounds-containing composition |
| 09/13/2007 | US20070212325 Insulin Resistance-Improving Agent |
| 09/13/2007 | US20070212322 cationic addition copolymers, use for hair, skin; polyTMAEAMS (methylsulfate[2-(acryloyloxy)ethyl]-trimethylammonium) first block (Mw=11,000 g/mole) and a polyacrylamide |
| 09/13/2007 | US20070212307 Pharmaceutical Compositions Comprising an Opioid Receptor Antagonist and Methods of Using Same |
| 09/13/2007 | US20070212302 Preparation and Use of a Stable Formulation of Allosteric Effector Compounds |
| 09/13/2007 | US20070212300 Delivery of compounds with rehydrated blood cells |
| 09/13/2007 | US20070209660 Intranasal Opioid Compositions, Delivery Devices and Methods of Using Same |
| 09/13/2007 | DE202006014513U1 Pharmazeutische Zusammensetzung, insbesondere Antazidum A pharmaceutical composition, in particular antacid |
| 09/13/2007 | DE19981169B4 Kovalent an Gallensäuren oder Sterine gebundenes Heparin, dessen Verwendung und diese enthaltende pharmazeutische Zusammensetzung Covalently bound to bile acids or sterols heparin, its use and these pharmaceutical composition containing |
| 09/13/2007 | DE19901270B4 Verfahren zur Flüssigkultivierung von Schizophyllum commune Fr. zur Isolierung von β-1,6-verzweigtem-β-1,3-Glucan Process for the liquid cultivation of Schizophyllum commune Fr. for the isolation of β-1,6-branched-β-1,3-glucan |
| 09/13/2007 | DE102006042615A1 Sicherung der Stabilität von Phytomenadion-haltigen flüssigen Arzneimittelzubereitungen zum Einnehmen mittels Zusatz von 0,01% Natriumedetat Ensuring the stability of phytomenadione-containing liquid pharmaceutical preparations for internal use by the addition of 0.01% sodium edetate |
| 09/13/2007 | DE102006011012A1 Verwendung von Zinkcysteinat zur Behandlung von Entzündungen oder Allergien der Atemwege Using Zinkcysteinat for treating inflammation or respiratory allergies |
| 09/13/2007 | DE102006010643A1 Using quaternary ammonium compounds to inhibit precipitation of fluoroquinolone antibiotics, particularly in ready-for-use formulations for veterinary medicine |
| 09/13/2007 | DE102006010329A1 Hormonelles Kontrazeptivum auf der Basis eines Estrogens, eines Gestagens oder einer Kombination von Estrogenen und Gestagenen unter der Zugabe von Testosteron Hormonal contraceptive on the basis of an estrogen, a progestogen or a combination of estrogens and progestins with the addition of testosterone |
| 09/13/2007 | DE102004028241B4 Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel New fluoroglycoside derivatives of pyrazoles, pharmaceutical compositions containing them and Manufacturing of these products |
| 09/13/2007 | CA2657606A1 Combination therapy with non-selective cox inhibitors to prevent cox-related gastric injuries |
| 09/13/2007 | CA2651943A1 Antiviral drugs for treatment of arenavirus infection |
| 09/13/2007 | CA2646884A1 The use of bupropion metabolites for the treatment of inflammatory disorders |
| 09/13/2007 | CA2646883A1 The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain |
| 09/13/2007 | CA2646882A1 The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain |
| 09/13/2007 | CA2646429A1 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders |
| 09/13/2007 | CA2646409A1 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 09/13/2007 | CA2645719A1 Compounds that modulate ppar activity, their preparation and use |
| 09/13/2007 | CA2645684A1 Compositions and methods of use of ritonavir for treating hcv |
| 09/13/2007 | CA2645320A1 Hormone replacement formulation |
| 09/13/2007 | CA2645318A1 Pharmaceutical formulations containing metformin |
| 09/13/2007 | CA2645227A1 Hydrazido derivatives of hyaluronic acid |
| 09/13/2007 | CA2645211A1 Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases |